Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy
NCT05988073 · View on ClinicalTrials.gov ↗
Study Summary
This prospective longitudinal study will follow participants with Multifocal Motor Neuropathy over time and collect data on their clinical outcomes, quality of life, and use of health care resources. Participants will follow their regular visit schedule with their treating physician, except for an optional second visit occurring 7 to 14 days after the start of the study to collect biomarker data. No IMP will be administered.
Conditions Studied
Study Locations (20)
California
- UCI Health - ALS and Neuromuscular Center — Orange
- Stanford Medicine Health Care - Stanford Neuroscience Health Center — Palo Alto
- The Neurology Group — Pomona
- Eisenhower Health - Rancho Mirage Medical Center — Rancho Mirage
- UC Davis Health - Lawrence J. Ellison Ambulatory Care Center — Sacramento
- UCSF Health - UCSF Medical Center — San Francisco
Arizona
- Neuromuscular Clinical and Research Center — Phoenix
- HonorHealth Neurology - Bob Bove Neuroscience Institute — Scottsdale
Florida
- Medsol Clinical Research Center Inc — Port Charlotte
- D&H National Research Centers - Tamarac Research Center — Tamarac
Colorado
- University of Colorado - Anschutz Medical Campus — Aurora
Connecticut
- YaleNewHavenHealth - Yale New Haven Hospital — New Haven
Illinois
- Hospital Sisters Health System (HSHS) - St Elizabeth's Hospital — O'Fallon
Kansas
- The University of Kansas Health System - Landon Center on Aging — Kansas City
Maryland
- MedStar Georgetown University Hospital — Chevy Chase
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 413 participants |
| Start Date | 2023-11-29 |
| Est. Completion | 2028-12-31 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05988073
The ClinicalTrials.gov registry entry for NCT05988073 describes a study currently listed as active not recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 413 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is argenx, which has 96 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Multifocal Motor Neuropathy appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05988073 reports 20 study locations spanning 13 distinct geographic areas — top geographies include California, Arizona, Florida. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05988073 about?
NCT05988073 is a clinical study titled "A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy". This prospective longitudinal study will follow participants with Multifocal Motor Neuropathy over time and collect data on their clinical outcomes, quality of life, and use of health care resources. Participants will follow their regular visit schedule with their treating physician, except for an o...
What is the current status of trial NCT05988073?
This trial is currently active not recruiting. The enrollment target is 413 participants. The study started on 2023-11-29. Estimated completion is 2028-12-31.
What conditions does trial NCT05988073 study?
This clinical trial studies the following conditions: Multifocal Motor Neuropathy. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT05988073?
This trial is sponsored by argenx, which has 96 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05988073 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.